Your browser doesn't support javascript.
loading
Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial.
Manjaly Thomas, Zita-Rose; Satti, Iman; Marshall, Julia L; Harris, Stephanie A; Lopez Ramon, Raquel; Hamidi, Ali; Minhinnick, Alice; Riste, Michael; Stockdale, Lisa; Lawrie, Alison M; Vermaak, Samantha; Wilkie, Morven; Bettinson, Henry; McShane, Helen.
Afiliação
  • Manjaly Thomas ZR; Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Satti I; Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Marshall JL; Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Harris SA; Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Lopez Ramon R; Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Hamidi A; Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Minhinnick A; Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Riste M; Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Stockdale L; Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Lawrie AM; Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Vermaak S; Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Wilkie M; Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Bettinson H; Oxford Centre for Respiratory Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • McShane H; Jenner Institute, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
PLoS Med ; 16(4): e1002790, 2019 04.
Article em En | MEDLINE | ID: mdl-31039172
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Aciltransferases / Vacinas contra a Tuberculose / Antígenos de Bactérias Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Female / Humans / Male Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Aciltransferases / Vacinas contra a Tuberculose / Antígenos de Bactérias Tipo de estudo: Clinical_trials / Guideline Limite: Adult / Female / Humans / Male Idioma: En Revista: PLoS Med Assunto da revista: MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido